These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 2544150

  • 1. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S, Fujita J, Yamaji Y, Futami H, Hashimoto Y, Bungo M, Iuchi Y, Kamei M, Nakamura H, Hata Y.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [Abstract] [Full Text] [Related]

  • 2. [A pilot study of etoposide, split-dose cisplatin and THP in small cell lung cancer].
    Matsui Y, Satake N, Kusume K, Kado M, Ohshima S, Yamamoto Y, Ishida H, Matsubara Y, Ikeda S.
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2567-72. PubMed ID: 1660701
    [Abstract] [Full Text] [Related]

  • 3. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 4. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H, Kawatsu H, Saka H, Yamamoto M, Takagi E, Tsunekawa H, Kawachi H, Nagura E, Sakai S, Nishiwaki K.
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [Abstract] [Full Text] [Related]

  • 5. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jun; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 6. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y, Fujita J, Kamei M, Futami H, Hashimoto Y, Bungo M, Nakamura H, Hata Y, Shiotani T, Irino S.
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [Abstract] [Full Text] [Related]

  • 7. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Honda R, Nishiwaki Y, Hino M, Hayashibe A, Yano H, Kitaya T, Matsuyama T.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
    [Abstract] [Full Text] [Related]

  • 8. [A combination phase II study of adriamycin, CDDP and etoposide in small cell lung cancer].
    Honda R, Fujita A, Inoue Y, Asakawa M, Tagaki S, Ohshima S, Suzuki A.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):375-9. PubMed ID: 2155585
    [Abstract] [Full Text] [Related]

  • 9. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
    Ueoka H, Ohnoshi T, Hiraki S, Kawahara S, Numata T, Nishii K, Yonei T, Yamashita H, Moritaka T, Kiura K.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 11. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
    Bando H, Takishita Y, Ogura T, Sone S, Shimizu E, Nakayama T, Doi H, Kobayashi M.
    Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
    [Abstract] [Full Text] [Related]

  • 12. [Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
    Miyamoto H, Kawakami Y, Arimoto T, Asakawa M, Suzuki A, Fujikane T, Onodera S, Nakabayashi T, Yasuda S, Shimizu T.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1127-34. PubMed ID: 1647149
    [Abstract] [Full Text] [Related]

  • 13. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [Abstract] [Full Text] [Related]

  • 14. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T, Fukuoka M, Negoro S, Sugiura T, Kawahara M, Kudoh S, Araki J, Nakagawa K, Yokozaki M, Yamakido M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1091-6. PubMed ID: 10945001
    [Abstract] [Full Text] [Related]

  • 15. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Jul; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B, Thongprasert S.
    J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
    [Abstract] [Full Text] [Related]

  • 17. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 19. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H, Bando H, Takishita Y.
    Anticancer Res; 1995 Dec; 15(2):613-6. PubMed ID: 7539241
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Dec; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.